Norris Medicines Ltd Approves Un-Audited Financial Results for Q3 & Year Ended 31st Dec, 2025

Key Highlights

• Norris Medicines Ltd has approved the Un-Audited Financial Results for the quarter and year ended 31st December, 2025.
• The approval was given at the Board Meeting held on 14th February, 2026.
• The results will be published in newspapers as per the prescribed format under Regulation 47 of Listing Regulations.
• The results are prepared in accordance with Indian Accounting Standards and other accounting principles generally accepted in India.
• The review of the results was conducted by Bahedia & Associates Chartered Accountants